Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1. Ability to comprehend and willingness to sign a written ICF for the study. <br/ >2. Male or non-pregnant females, â?¥18 years of age at the time of enrolment. <br/ >3. Understands and agrees to comply with planned study procedures. <br/ >4. Agrees to the collection of pharyngeal swabs and blood sample as per protocol. <br/ >5. Has laboratory-confirmed SARS-CoV-2 infection as determined by PCR, or other <br/ >commercial or public health assay in any specimen <br/ >6.Women of childbearing potential must agree to use at least one primary form of <br/ >contraception for the duration of the study (acceptable methods will be determined <br/ >by the site).

1. Ability to comprehend and willingness to sign a written ICF for the study. <br/ >2. Male or non-pregnant females, â?¥18 years of age at the time of enrolment. <br/ >3. Understands and agrees to comply with planned study procedures. <br/ >4. Agrees to the collection of pharyngeal swabs and blood sample as per protocol. <br/ >5. Has laboratory-confirmed SARS-CoV-2 infection as determined by PCR, or other <br/ >commercial or public health assay in any specimen <br/ >6.Women of childbearing potential must agree to use at least one primary form of <br/ >contraception for the duration of the study (acceptable methods will be determined <br/ >by the site).

Nov. 13, 2021, 5:33 p.m. oms

Oct. 26, 2020, 8:29 a.m. oms

1. Ability to comprehend and willingness to sign a written ICF for the study. <br/ >2. Male or non-pregnant females, â?¥18 years of age at the time of enrolment. <br/ >3. Understands and agrees to comply with planned study procedures. <br/ >4. Agrees to the collection of pharyngeal swabs and blood sample as per protocol. <br/ >5. Has laboratory-confirmed SARS-CoV-2 infection as determined by PCR, or other <br/ >commercial or public health assay in any specimen <br/ >6.Women of childbearing potential must agree to use at least one primary form of <br/ >contraception for the duration of the study (acceptable methods will be determined <br/ >by the site).

1. Ability to comprehend and willingness to sign a written ICF for the study. <br/ >2. Male or non-pregnant females, â?¥18 years of age at the time of enrolment. <br/ >3. Understands and agrees to comply with planned study procedures. <br/ >4. Agrees to the collection of pharyngeal swabs and blood sample as per protocol. <br/ >5. Has laboratory-confirmed SARS-CoV-2 infection as determined by PCR, or other <br/ >commercial or public health assay in any specimen <br/ >6.Women of childbearing potential must agree to use at least one primary form of <br/ >contraception for the duration of the study (acceptable methods will be determined <br/ >by the site).